Abstract

Two binding sites are associated with neurokinin-1 substance P receptors in both transfected cells and mammalian tissues. To further delineate the interactions between the crucial C-terminal methionine of substance P and these two binding sites, we have incorporated newly designed constrained methionines, i.e. (2S, 3S)- and (2S,3R)-prolinomethionines. The potencies of these C terminus-modified SP analogues to bind both sites and to activate phosphatidylinositol hydrolysis and cAMP formation have been measured, together with those of their corresponding sulfoxides and sulfones. The molecular nature of these two binding sites and their selective coupling to effector signaling pathways are discussed in the light of current models of receptor activation. The less abundant binding site is coupled to G(q/11) proteins, whereas the most abundant one interacts with G(s) proteins in Chinese hamster ovary cells transfected with human neurokinin-1 receptors. The specific orientation of the C-terminal methionine side chain imposed by these constraints shows that macroscopically chi(1) and chi(2) angles of this crucial C-terminal residue are similar in both binding sites. However, slight but significant variations in the rotation around the Cgamma-S bond yield different either stabilizing or destabilizing interactions in the two binding sites. These results highlight the need of such constrained amino acids to probe subtle interactions in ligand-receptor complexes.

Highlights

  • The complex formed by substance P ((SP)1 Arg-Pro-Lys-ProGln-Gln-Phe-Phe-Gly-Leu-Met-NH2)2 and the human NK-1 tachykinin receptor has been selected for this investigation, as we and others have established that two binding sites associated with this receptor are found both in transfected cell lines [6, 7] and in a mammalian tissue [7]

  • It has recently been reported that hNK-1 receptor transfected in CHO cells directly activates G␣q/11, G␣s, and G␣0 proteins [24] and that there is no cross-talk between cAMP accumulation and IP formation [23, 25, 26]

  • It is likely that EC50 values of all SP analogues measured in this study arise from direct NK-1 receptor/G protein coupling

Read more

Summary

The following peptides were used in the linear regression analyses

Thr-Asp-Ser-Phe-Val-Gly-Leu-Met-NH2; Ac-Arg-septide, acetyl-PhePhe-Pro-Leu-Met-NH2; [Gly9-⌿(CH2CH2)-Gly10]SP; [pGlu6]SP(6 –11); [Lys5]NKA(4 –10); [Sar, Met(O2)11]SP; [Gly9-⌿(CH2CH2)-Leu10]SP; [Bapa0(pBz)Phe8,Pro9]SP; [Bapa0(⑀C2H5CO)Lys3(pBz)Phe, Pro9]SP; propionyl[Met(O2)11]SP[7,8,9,10,11]; [Flg7]SP; [Flg8]SP; [Dip7]SP; [Dip8]SP; [(2S,3S)Ing7]SP; [(2S,3R)Ing7]SP; [(2S,3S)Bfi8]SP; [(2S,3R)Bfi8]SP; [(2S,3S)Ing7]SP; [Flg8]SP; [Tic8]SP; [⌬ZNal8]SP; [⌬EPhe7]SP; [Dmp7]SP; [Dmp8]SP; [(Tms)Ala8]SP; [␣MeMet11]SP; [␣MeLeu10]SP; [Aib9]SP; [␣MePhe8]SP; [␣MeMet6]SP; [␣MeMet5]SP; [Arg0]NKB; [(⑀C2H5CO)Lys0(pBz)Phe, Pro9]SP[7,8,9,10,11]; [(⑀C2H5CO)Lys0(pBz)Phe, Pro, Met(O2)11]SP[7,8,9,10,11]; [Bapa(⑀C2H5CO)Lys0(pBz)Phe, Pro, Met(O2)11]SP[7,8,9,10,11]; [Bapa0, Flg8(pBz, SO2)Hcy11]SP; [DGln5]SP; [Aib5]SP; [Hcy, Pen8]SP; [Nle11]SP; [Pro11]SP; [Met(O)11]SP; [Met(O2)11]SP; [P3EMet11]SP; [P3EMet(O)11]SP; [P3EMet(O2)11]SP; [P3ZMet11]SP; [P3ZMet(O)11]SP; [P3ZMet(O2)11]SP. To further delineate the molecular interactions of this C-terminal amino acid with both binding sites of the human NK-1 tachykinin receptor, we have designed constrained analogues of methionine, i.e. 3-prolinomethionines (Fig. 1) [16, 17]. Because the sulfoxides and sulfone analogues of SP and propionyl-SP[7,8,9,10,11] have previously led to striking results [7], the oxidized (sulfoxides and sulfone) derivatives of both [P3ZMet11]SP and [P3EMet11]SP have been used to investigate the orientation(s) of the methionine side chain in both binding sites in CHO cells transfected with the human tachykinin NK-1 receptor

EXPERIMENTAL PROCEDURES
RESULTS
40 Ϯ 15 40 Ϯ 7 145 Ϯ 25
DISCUSSION
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call